Books+ Search Results
Brain Protection in Schizophrenia, Mood and Cognitive Disorders
Title
Brain Protection in Schizophrenia, Mood and Cognitive Disorders [electronic resource] / edited by Michael S. Ritsner.
ISBN
9789048185535
Edition
1st ed. 2010.
Publication
Dordrecht : Springer Netherlands : Imprint: Springer, 2010.
Physical Description
1 online resource (XV, 663 p.)
Local Notes
Access is available to the Yale community.
Access and use
Access restricted by licensing agreement.
Summary
Neuroprotection is a novel perspective for the treatment of disorders that lead to neurodegeneration and disabilities as a result of deterioration of neurons due to apoptosis, oxidative stress, excitotoxicity, and other mechanisms. These mechanisms have implications not only for neurodegenerative disorders, but also for schizophrenia, mood and cognitive disorders. The purpose of this book is to provide an up-to-date overview of basic and clinical studies concerning the neuroprotective approach, mechanisms, and several compounds with neuroprotective properties that may contribute to more efficacious treatment of major mental health disorders. The book is divided into two sections. The first section serves as an introduction and overview of conceptual issues of the neuroprotective approach, and some neurobiological advances. Chapters in this section review definitions, perspectives, and issues that provide a conceptual base for the rest of the book. In addition, this part includes chapters in which the authors present and discuss the findings from basic studies of neurodegenerative mechanisms that are associated with the pathogenesis of major mental health disorders. The second section focuses on findings obtained from clinical trials with neuroprotective compounds, and neuromodulatory techniques. The take-home message is that principles of the neuroprotective approach may be applied to treatment of schizophrenia, mood and cognitive disorders. Contributors to this book are among the most active investigators and clinicians in the field who provide new perspectives not only clarifying ongoing controversies but also propose diverse aspects and new insights to neuroprotection. This book is intended for a broad readership, which includes a broad spectrum of readers including neuroscientists, psychiatrists, neurologists, pharmacologists, clinical psychologists, general practitioners, geriatricians, graduate students, and policy makers in the fields of mental health.
Variant and related titles
Springer ENIN.
Other formats
Printed edition:
Printed edition:
Printed edition:
Format
Books / Online
Language
English
Added to Catalog
August 11, 2023
Contents
Neuroprotective Strategies and Mechanisms
Brain Protection in Neuropsychiatric Disorders: Past, Present and Future Challenges
Towards a New Paradigm in Neuroprotection and Neuroplasticity
What Protects Patients with Schizophrenia from Developing Alzheimer Pathology?
Assessing In Vivo Neurodegeneration in Schizophrenia Using Magnetic Resonance
Vulnerability of the Brain to Neuropsychiatric Disorders Resulting from Abnormal Thyroid Hormone or Vitamin D Homeostasis
Phosphatidylinositol 3-Kinase/Glycogen Synthase Kinase and Mitogen-Activated Protein Kinase Signalling Cascades in Neuronal Cell Survival: What the Neurotrophins Have Taught Us and Implications For Neuropsychiatric Disorders
One-Compound-Multi-Targets at Amyloid ? Cascade Offered By Bis(7)-Cognitin, a Novel Anti-Alzheimer's Dimer
Common Pathways to Neurodegeneration and Co-morbid Depression
Breakdown of the Blood-Brain Barrier in Stress Alters Cognitive Dysfunction and Induces Brain Pathology: New Perspectives for Neuroprotective Strategies
Oxidative Stress and Neurodegeneration: An Inevitable Consequence of Aging? Implications for Therapy
Carbon Nanotubes as Electrical Interfaces with Neurons
II. Neuroprotective Treatment and Neuromodulation
Is a Neuroprotective Therapy Suitable for Schizophrenia Patients?
Recombinant Human Erythropoietin: Novel Approach to Neuroprotection and Neuroregeneration in Schizophrenia
Neuroprotective Agents in Mood Disorders: Pathophysiological and Therapeutic Implications
Neuroprotection in Bipolar Depression
New Antiepileptic Drugs in Neuropsychiatric Disorders - Basic Mechanisms Related to Clinical Efficacy
The Neuroprotective Efficacy of Vitamins
Smoking and Mental Disorders: Focus on Neuroprotection
Inhibition of Glycine Transporter-1 Improves the Functional Outcome of Schizophrenia
The Role of Oxytocin in Neuropsychiatric Disorders: Concepts and Mechanisms
Neuromodulation for Neuropsychiatric Disorders: Novel Techniques -Vagus Nerve Stimulation, Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, and Deep Brain Stimulation.
Subjects
Also listed under
SpringerLink (Online service)
Bookmark As
Citation
